Yu Yong 4

What Happened
Yu Yong, Senior Vice President, Clinical Development at GENELUX (GNLX), disposed of 906 shares on 2026-03-24 in an open market/private sale at $2.42 per share for total proceeds of $2,193. According to the filing footnote, the shares were sold to cover the Reporting Person’s estimated tax obligations arising from the vesting of restricted stock units (RSUs). This is a sale (routine tax-withholding), not a purchase.

Key Details

• Transaction date and price: 2026-03-24 — 906 shares at $2.42 each.
• Total proceeds: $2,193.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnote: F1 — Shares sold to cover estimated taxes related to RSU vesting (tax withholding).
• Filing date: Form 4 filed 2026-03-26 for the 2026-03-24 transaction (filed within the typical 2-business-day window).

Context
Sales to cover taxes on vested RSUs are common and are generally considered routine administrative transactions rather than directional bets on the company. The dollar amount here ($2.2K) is small relative to typical insider trades, and the filing does not indicate any new purchases, option exercises, or changes in control.